As of May 2026 MoonLake Immunotherapeutics has a market cap of NZ$2.29 Billion. This makes MoonLake Immunotherapeutics the world's 5587th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On May 25th, 2026 the market cap of MoonLake Immunotherapeutics was reported to be: